Literature DB >> 23770934

Meta-analysis of cognitive deficits in ultra-high risk to psychosis and first-episode psychosis: do the cognitive deficits progress over, or after, the onset of psychosis?

Emre Bora1, Robin M Murray2.   

Abstract

Cognitive dysfunction is a well-established feature of schizophrenia, and there is evidence suggesting that cognitive deficits are secondary to abnormal neurodevelopment leading to problems in acquiring such abilities. However, it is not clear whether there is also a decline in cognitive performance over, or after, the onset of psychosis. Our objective was to quantitatively examine the longitudinal changes in cognitive function in patients who presented with first-episode psychosis (FEP), ultra-high risk (UHR) for psychosis, and controls. Electronic databases were searched for the studies published between January 1987 and February 2013. All studies reporting longitudinal cognitive data in FEP and UHR subjects were retrieved. We conducted meta-analyses of 25 studies including 905 patients with FEP, 560 patients at UHR, and 405 healthy controls. The cognitive performances of FEP, UHR, and healthy controls all significantly improved over time. There was no publication bias, and distributions of effect sizes were very homogenous. In FEP, the degree of improvement in verbal working memory and executive functions was significantly associated with reduction in negative symptoms. There was no evidence of cognitive decline in patients with UHR and FEP. In contrast, the cognitive performances of both groups improved at follow-up. These findings suggest that cognitive deficits are already established before the prodromal phases of psychosis. These data support the neurodevelopmental model rather than neurodegenerative and related staging models of schizophrenia.
© The Author 2013. Published by Oxford University Press on behalf of the Maryland Psychiatric Research Center. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  cognition; longitudinal; neuropsychology; psychosis; schizophrenia

Mesh:

Year:  2013        PMID: 23770934      PMCID: PMC4059428          DOI: 10.1093/schbul/sbt085

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  70 in total

1.  Practice effects on commonly used measures of executive function across twelve months.

Authors:  M R Basso; R A Bornstein; J M Lang
Journal:  Clin Neuropsychol       Date:  1999-08       Impact factor: 3.535

2.  Practice effects on the Wisconsin Card Sorting Test-64 Card version across 12 months.

Authors:  M R Basso; N Lowery; C Ghormley; R A Bornstein
Journal:  Clin Neuropsychol       Date:  2001-12       Impact factor: 3.535

3.  Neurocognitive predictors of functional outcome two to 13 years after identification as ultra-high risk for psychosis.

Authors:  A Lin; S J Wood; B Nelson; W J Brewer; D Spiliotacopoulos; A Bruxner; C Broussard; C Pantelis; A R Yung
Journal:  Schizophr Res       Date:  2011-07-16       Impact factor: 4.939

4.  Neuropsychological performance in older patients with schizophrenia: a meta-analysis of cross-sectional and longitudinal studies.

Authors:  Farzin Irani; Solomon Kalkstein; Emily A Moberg; Paul J Moberg
Journal:  Schizophr Bull       Date:  2010-06-14       Impact factor: 9.306

5.  Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia.

Authors:  S E Purdon; B D Jones; E Stip; A Labelle; D Addington; S R David; A Breier; G D Tollefson
Journal:  Arch Gen Psychiatry       Date:  2000-03

6.  Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies.

Authors:  Bayanne Olabi; Ian Ellison-Wright; Andrew M McIntosh; Stephen J Wood; Ed Bullmore; Stephen M Lawrie
Journal:  Biol Psychiatry       Date:  2011-03-31       Impact factor: 13.382

Review 7.  Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group.

Authors:  D F Stroup; J A Berlin; S C Morton; I Olkin; G D Williamson; D Rennie; D Moher; B J Becker; T A Sipe; S B Thacker
Journal:  JAMA       Date:  2000-04-19       Impact factor: 56.272

Review 8.  Neurocognition in the psychosis risk syndrome: a quantitative and qualitative review.

Authors:  Anthony J Giuliano; Huijun Li; Raquelle I Mesholam-Gately; Shannon M Sorenson; Kristen A Woodberry; Larry J Seidman
Journal:  Curr Pharm Des       Date:  2012       Impact factor: 3.116

9.  Executive functioning correctly classified diagnoses in patients with first-episode psychosis: evidence from a 2-year longitudinal study.

Authors:  Javier Peña; Natalia Ojeda; Rafael Segarra; Jose Ignacio Eguiluz; Jon García; Miguel Gutiérrez
Journal:  Schizophr Res       Date:  2010-10-20       Impact factor: 4.939

Review 10.  Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature.

Authors:  Vasilis P Bozikas; Christina Andreou
Journal:  Aust N Z J Psychiatry       Date:  2011-02       Impact factor: 5.744

View more
  112 in total

1.  Genetic Variation in Schizophrenia Liability is Shared With Intellectual Ability and Brain Structure.

Authors:  Marc M Bohlken; Rachel M Brouwer; René C W Mandl; René S Kahn; Hilleke E Hulshoff Pol
Journal:  Schizophr Bull       Date:  2016-04-07       Impact factor: 9.306

2.  Differentiating between clinical and behavioral phenotypes in first-episode psychosis during maintenance of visuospatial working memory.

Authors:  Maria Jalbrzikowski; Vishnu P Murty; Patricia L Stan; Jusmita Saifullan; Daniel Simmonds; William Foran; Beatriz Luna
Journal:  Schizophr Res       Date:  2017-11-11       Impact factor: 4.939

Review 3.  Community participation factors and poor neurocognitive functioning among persons with schizophrenia.

Authors:  Elizabeth C Thomas; Gretchen Snethen; Mark S Salzer
Journal:  Am J Orthopsychiatry       Date:  2019-01-24

Review 4.  Research strategies and priorities to improve the lives of people with schizophrenia: executive summary of the Ernst Strüngmann Forum on schizophrenia.

Authors:  Steven M Silverstein; Bita Moghaddam; Til Wykes
Journal:  Schizophr Bull       Date:  2014-01-28       Impact factor: 9.306

5.  Brain Age in Early Stages of Bipolar Disorders or Schizophrenia.

Authors:  Tomas Hajek; Katja Franke; Marian Kolenic; Jana Capkova; Martin Matejka; Lukas Propper; Rudolf Uher; Pavla Stopkova; Tomas Novak; Tomas Paus; Miloslav Kopecek; Filip Spaniel; Martin Alda
Journal:  Schizophr Bull       Date:  2019-01-01       Impact factor: 9.306

Review 6.  Negative Symptoms and Cognitive Impairments in Schizophrenia: Two Key Symptoms Negatively Influencing Social Functioning.

Authors:  Koichi Kaneko
Journal:  Yonago Acta Med       Date:  2018-06-18       Impact factor: 1.641

7.  Gender Differences in Social Cognition: A Cross-Sectional Pilot Study of Recently Diagnosed Patients with Schizophrenia and Healthy Subjects.

Authors:  Guillem Navarra-Ventura; Sol Fernandez-Gonzalo; Marc Turon; Esther Pousa; Diego Palao; Narcis Cardoner; Merce Jodar
Journal:  Can J Psychiatry       Date:  2017-12-07       Impact factor: 4.356

8.  Nonsocial and social cognition in schizophrenia: current evidence and future directions.

Authors:  Michael F Green; William P Horan; Junghee Lee
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

9.  Neurocognitive profiles in the prodrome to psychosis in NAPLS-1.

Authors:  Eva Velthorst; Eric C Meyer; Anthony J Giuliano; Jean Addington; Kristin S Cadenhead; Tyrone D Cannon; Barbara A Cornblatt; Thomas H McGlashan; Diana O Perkins; Ming T Tsuang; Elaine F Walker; Scott W Woods; Carrie E Bearden; Larry J Seidman
Journal:  Schizophr Res       Date:  2018-08-02       Impact factor: 4.939

10.  Driving skills in unmedicated first- and recurrent-episode schizophrenic patients.

Authors:  Felix M Segmiller; Verena Buschert; Gerd Laux; N Nedopil; Ulrich Palm; Katharina Furjanic; Peter Zwanzger; Alexander Brunnauer
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-10-25       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.